Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4758 USD | +0.01% | -2.30% | -86.89% |
04-08 | Kineta, Inc. Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 Vista-101 Clinical Trial | CI |
03-21 | Earnings Flash (KA) KINETA Posts 2023 Revenue $5.4M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-86.89% | 5.4M | |
+10.57% | 115B | |
+12.40% | 106B | |
-5.38% | 24.69B | |
-1.22% | 21.97B | |
-4.87% | 19.27B | |
-11.04% | 17.56B | |
-39.36% | 17.32B | |
+5.95% | 14.03B | |
+33.62% | 12.13B |
- Stock Market
- Equities
- KA Stock
- News Kineta, Inc.
- Kineta Closes $6 Million Registered Direct Offering